Insulin sensitivity and secretion changes after gastric bypass in normotolerant and diabetic obese subjects

Annals of Surgery

Volumn 257, Issue 3, 2013, Pages 462-468

  Salinari, Serenella ^a   Bertuzzi, Alessandro ^b   Guidone, Caterina ^c   Previti, Elena ^a   Rubino, Francesco ^d   Mingrone, Geltrude ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CNR   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

gastric bypass; insulin secretion; insulin sensitivity; obesity type 2 diabetes

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; SULFONYLUREA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE DURATION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; INSULIN RELEASE; INSULIN SENSITIVITY; INSULIN TREATMENT; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; STOMACH BYPASS;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRIC BYPASS; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; OBESITY, MORBID; TREATMENT OUTCOME;

EID: 84873886456     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e318269cf5c     Document Type: Article

References (38)

1. Iaconelli A, Panunzi S,DeGaetanoA, et al. Effects of bilio-pancreatic diversion on diabetes complications: a 10-year follow-up. Diabetes Care. 2011;34:561-567.
2. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299:316-323.
3. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248-256.
4. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222:339-352.
5. Pories WJ, Albrecht RJ. Etiology of type II diabetes mellitus: role of the foregut. World J Surg. 2001;25:527-531.
6. Cummings DE. Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery. Int J Obes (Lond). 2009;33:S33-S40.
7. Pories WJ. Diabetes: the evolution of a new paradigm. Ann Surg. 2004;239:12-13.
8. Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238:467-485.
9. Sj̈ostr̈om L, Narbro K, Sj̈ostr̈om CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741-752.
10. Adams TD, Gress RE, Smith SC, et al. Long-termmortality after gastric bypass surgery. N Engl J Med. 2007;357:753-761.
11. le Roux CW, Aylwin SJ, Batterham RL, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg. 2006;243:108-114.
12. Korner J, Bessler M, Inabnet W, et al. Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surg Obes Relat Dis. 2007;3:597-601.
13. Schauer PR, Ikramuddin S, Gourash W, et al. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg. 2000;232:515-529.
14. DiGiorgi M, Rosen DJ, Choi JJ, et al. Re-emergence of diabetes after gastric bypass in patients with mid-to long-term follow-up. Surg Obes Relat Dis. 2010;6:249-253.
15. Roslin M, Damani T, Oren J, et al. Abnormal glucose tolerance testing following gastric bypass demonstrates reactive hypoglycemia. Surg Endosc. 2011;25:1926-1932.
16. Kellogg TA, Bantle JP, Leslie DB, et al. Postgastric bypass hyperinsulinemic hypoglycemia syndrome: characterization and response to a modified diet. Surg Obes Relat Dis. 2008;4:492-499.
17. Marsk R, Jonas E, Rasmussen F, et al. Nationwide cohort study of post-gastric bypass hypoglycaemia including 5,040 patients undergoing surgery for obesity in 1986-2006 in Sweden. Diabetologia. 2010;53:2307-2311.
18. Laferr̀ere B, Teixeira J,McGinty J, et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab. 2008;93:2479-2485.
19. Kashyap SR, Daud S, Kelly KR, et al. Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. Int J Obes (Lond). 2010;34:462-471.
20. Lin E, Liang Z, Frediani J, et al. Improvement in β-cell function in patients with normal and hyperglycemia following Roux-en-Y gastric bypass surgery. Am J Physiol Endocrinol Metab. 2010;299:E706-E712.
21. Greco AV, Mingrone G, Giancaterini A, et al. Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes. 2002;51:144-151.
22. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214-E223.
23. Bertuzzi A, Salinari S, Mingrone G. Insulin granule trafficking in beta-cells: mathematical model of glucose-induced insulin secretion. Am J Physiol Endocrinol Metab. 2007;293:E396-E409.
24. Caumo A, Bergman RN, Cobelli C. Insulin sensitivity from meal tolerance test in normal subjects: a minimal model index. J Clin Endocrinol Metab. 2000;85:4396-4402.
25. Toffolo G, Cefalu WT, Cobelli C. Beta-cell function during insulin-modified intravenous glucose tolerance test successfully assessed by the C-peptide minimal model. Metabolism. 1999;48:1162-1166.
26. Breda E, Cavaghan MK, Toffolo G, et al. Oral glucose tolerance test minimal model indexes of β-cell function and insulin sensitivity. Diabetes. 2001;50:150-158.
27. Salinari S, Bertuzzi A, Iaconelli A, et al. Twenty-four hour insulin secretion and beta cell NEFA oxidation in type 2 diabetic,morbidly obese patients before and after bariatric surgery. Diabetologia. 2008;51:1276-1284.
28. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85:2402-2410.
29. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
30. Laferr̀ere B, Heshka S, Wang K, et al. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care. 2007;30:1709-1716.
31. Bose M, Teixeira J, Olivan B, et al. Weight loss and incretin responsiveness improve glucose control independently after gastric bypass surgery. JDiabetes. 2010;2:47-55.
32. Quddusi S, Vahl TP, Hanson K, et al. Differential effects of acute and extended infusions of glucagon-like peptide-1 of first-and second-phase insulin secretion in diabetic and nondiabetic humans. Diabetes Care. 2003;26:791-798.
33. Salinari S, Bertuzzi A, Asnaghi S, et al. First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery. Diabetes Care. 2009;32:375-380.
34. Muscelli E, Mingrone G, Camastra S, et al. Differential effect of weight loss on insulin resistance in surgically treated obese patients. Am JMed. 2005;118:51-57.
35. Lima MM, Pareja JC, Alegre SM, et al. Acute effect of Roux-en-Y gastric bypass on whole-body insulin sensitivity: a study with the euglycemic- hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95:3871-3875.
36. Ferrannini E, Mingrone G. Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes. Diabetes Care. 2009;32:514-552.
37. Ballantyne GH, Farkas D, Laker S, et al. Short-term changes in insulin resistance following weight loss surgery for morbid obesity: laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2006;16:1189-1197.
38. Markovic TP, Jenkins AB, Campbell LV, et al. The determinants of glycemic responses to diet restriction and weight loss in obesity and NIDDM. Diabetes Care. 1998;21:687-694.